GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

Carmot acquisition propels Roche to forefront of obesity drug leadership, finds GlobalData

In a significant move in December 2023, Roche completed the acquisition of the US-based company Carmot Therapeutics in a deal worth $2.9 billion. This strategic acquisition provides Roche access to Carmot’s portfolio, which notably includes three lead molecules, all GLP-1 analogues, currently in the advanced stages of clinical trials for obesity and type 2 diabetes. […]
Read more

Influencers on X opine ETFs will enhance Bitcoin’s credibility among investors, reveals GlobalData

Over a decade after the first application, the US Securities and Exchange Commission (SEC) has approved all 11 applications for spot bitcoin (Exchange Traded Funds (ETFs), which is a significant development for the cryptocurrency industry. In line with this, social media discussions (‘X’ platform) around “Bitcoin” spiked up 90% over the last seven days, reveals […]
Read more

GlobalData’s Technology Foresights reveals Sony headset launched at CES 2024 competes head-to-head with Apple’s Vision Pro

The opening day of CES 2024 witnessed a flurry of product launches, notably Sony Corp’s surprising entry into the mixed reality headset arena. Tailored for spatial content creators, the headset is anticipated to hit the market later this year. Simultaneously, Apple revealed that its flagship spatial computing headset, the Vision Pro, showcased last year, will […]
Read more

AbbVie’s Produodopa holds potential to become first-choice pump for advanced Parkinson’s, says GlobalData

Following the news that  AbbVie has launched Produodopa (foscarbidopa/foslevodopa), to treat severe motor fluctuations in patients with advanced Parkinson’s disease (PD) in the European Union (EU). Christie Wong, Neurology Analyst at GlobalData, a leading data and analytics company, offers her view: “AbbVie’s Produodopa is the first-to-market subcutaneous infusion of levodopa. Produodopa uses a VYAFUSER pump […]
Read more

Biotech funding recovery is on the horizon in 2024, says GlobalData

Over 2022 and 2023, biotech funding saw significant change, with a marked downturn in investment. Hoverer, the post-pandemic slump is expected to end with the market heading to recovery in 2024, finds GlobalData, a leading data and analytics company. A recent GlobalData’s survey “The State of the Biopharmaceutical Industry 2024” found that overall, more than […]
Read more

Enterprises must navigate through challenges to ensure responsible and ethical deployment of AI solutions, says GlobalData

Generative AI has raised new challenges related to ‘Responsible AI’, catapulting concerns into the headlines and forcing enterprises to revisit their AI policies at a time when they investigate new potential applications. Enterprises need to ensure that AI solutions are implemented in a responsible and ethical way, says GlobalData, a leading data and analytics company. […]
Read more

Telecom and pay-TV services revenue in South Korea to increase at 10.3% CAGR over 2023-28, forecasts GlobalData

The telecom and pay-TV services revenue in South Korea is forecast to increase at a compounded annual growth rate (CAGR) of 10.3% during 2023-2028, supported by strong growth in the mobile data segment, according to GlobalData, a leading data and analytics company. GlobalData’s South Korea Telecom Operators Country Intelligence Report reveals that the mobile data […]
Read more
1 90 91 92 93 94 136